Massimo Galli Selected Research

Massimo Galli Research Topics

Disease

45	Infections 05/2022 - 03/2004
37	COVID-19 05/2022 - 01/2020
18	HIV Infections (HIV Infection) 12/2021 - 08/2003
11	Acquired Immunodeficiency Syndrome (AIDS) 06/2021 - 12/2002
7	Coinfection 11/2018 - 04/2011
6	Disease Progression 01/2021 - 01/2005
6	Vasculitis (Vasculitides) 01/2021 - 06/2011
5	Chronic Hepatitis C 05/2021 - 02/2006
5	Cryoglobulinemia 01/2021 - 11/2011
5	Communicable Diseases (Infectious Diseases) 09/2020 - 01/2014
5	Fatigue 08/2019 - 01/2010
4	Liver Diseases (Liver Disease) 12/2021 - 11/2010
4	Body Weight (Weight, Body) 06/2021 - 01/2005
4	Rheumatoid Arthritis 01/2021 - 11/2017
4	Viremia 01/2019 - 12/2010
3	Fever (Fevers) 12/2021 - 01/2020
3	Human Influenza (Influenza) 01/2021 - 04/2003
3	Pneumonia (Pneumonitis) 12/2020 - 01/2020
3	Respiratory Insufficiency (Respiratory Failure) 11/2020 - 05/2017
3	Thrombocytopenia (Thrombopenia) 01/2020 - 11/2010
3	Glomerulonephritis 08/2019 - 06/2011
3	Peripheral Nervous System Diseases (PNS Diseases) 08/2019 - 12/2002
3	Neoplasms (Cancer) 04/2013 - 12/2002
3	Lipodystrophy 09/2008 - 08/2003
2	Herpes Zoster 09/2022 - 10/2019
2	Rheumatic Diseases (Rheumatism) 05/2021 - 01/2021
2	Inflammation (Inflammations) 01/2021 - 07/2020
2	Pain (Aches) 01/2021 - 02/2015
2	Type 2 Diabetes Mellitus (MODY) 12/2020 - 07/2020
2	Sexually Transmitted Diseases (Sexually Transmitted Disease) 03/2020 - 01/2014
2	Critical Illness (Critically Ill) 01/2020 - 10/2016
2	Opportunistic Infections (Opportunistic Infection) 10/2019 - 12/2014
2	Skin Ulcer 08/2019 - 06/2011
2	Hepatitis B 01/2018 - 10/2017
2	Arthralgia (Joint Pain) 03/2017 - 02/2015
2	Purpura 03/2017 - 02/2015
2	Fibrosis (Cirrhosis) 06/2015 - 04/2011
2	Lymphopenia (Lymphocytopenia) 12/2010 - 06/2010
2	Hypersensitivity (Allergy) 01/2007 - 06/2003
1	Crohn Disease (Crohn's Disease) 09/2022
1	Venous Thromboembolism 04/2022
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022
1	Alcoholism (Alcohol Abuse) 12/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2021
1	Wounds and Injuries (Trauma) 07/2021

Drug/Important Bio-Agent (IBA)

10	Pharmaceutical PreparationsIBA 10/2020 - 08/2003
9	Antiviral Agents (Antivirals)IBA 12/2021 - 06/2015
8	VaccinesIBA 09/2022 - 08/2007
8	InterferonsIBA 11/2016 - 02/2006
7	Immunoglobulin G (IgG)IBA 12/2021 - 01/2015
7	Biological ProductsIBA 01/2021 - 09/2014
7	Ribavirin (Virazole)FDA LinkGeneric 02/2015 - 02/2006
6	RNA (Ribonucleic Acid)IBA 11/2021 - 03/2005
6	Rituximab (Mabthera)FDA Link 05/2021 - 06/2011
5	CytokinesIBA 01/2022 - 04/2003
5	AntibodiesIBA 02/2021 - 01/2013
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2010
4	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2021 - 12/2020
4	Indicators and Reagents (Reagents)IBA 10/2020 - 01/2016
4	Protease Inhibitors (Protease Inhibitor)IBA 10/2014 - 05/2004
3	COVID-19 VaccinesIBA 05/2022 - 01/2021
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 04/2003
3	BNT162 VaccineIBA 12/2021 - 01/2021
3	Hepatitis B Surface Antigens (HBsAg)FDA Link 12/2021 - 03/2012
3	LipidsIBA 06/2021 - 03/2005
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 06/2019
3	Lopinavir FDA Link 01/2021 - 03/2004
3	tocilizumab (atlizumab)FDA Link 01/2021 - 01/2020
3	remdesivirIBA 01/2021 - 01/2020
3	Alanine Transaminase (SGPT)IBA 11/2020 - 11/2010
3	EnzymesIBA 01/2020 - 02/2006
3	nitinolIBA 08/2019 - 01/2010
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2019
2	mRNA VaccinesIBA 01/2022 - 01/2021
2	Messenger RNA (mRNA)IBA 12/2021 - 01/2021
2	dolutegravirIBA 06/2021 - 01/2021
2	Ritonavir (Norvir)FDA Link 01/2021 - 01/2021
2	AntigensIBA 01/2021 - 04/2003
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 04/2010
2	Vitamin D FDA LinkGeneric 01/2021 - 04/2011
2	Darunavir (Prezista)FDA Link 01/2021 - 01/2014
2	Dipeptidyl-Peptidase IV InhibitorsIBA 12/2020 - 07/2020
2	CreatinineIBA 01/2020 - 01/2013
2	Antirheumatic Agents (DMARD)IBA 11/2019 - 11/2017
2	GoldIBA 07/2019 - 03/2019
2	Nevirapine (Viramune)FDA Link 11/2018 - 01/2018
2	Interleukin-7 (Interleukin 7)IBA 12/2010 - 06/2004
2	tucaresolIBA 09/2005 - 08/2004
1	2-mercaptopurineIBA 09/2022
1	Interleukin-8 (Interleukin 8)IBA 12/2021
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 12/2021
1	SuspensionsIBA 07/2021
1	RacivirIBA 06/2021
1	Rilpivirine (TMC-278)IBA 06/2021

Therapy/Procedure

23	Therapeutics 09/2022 - 04/2003
12	Highly Active Antiretroviral Therapy (HAART) 01/2016 - 12/2002
4	Art Therapy 01/2021 - 08/2003
3	Artificial Respiration (Mechanical Ventilation) 11/2020 - 05/2017
3	Drug Therapy (Chemotherapy) 07/2014 - 12/2002
2	Off-Label Use 01/2021 - 01/2020